Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2008, p. 3198-3207, Vol. 28, No. 10
0270-7306/08/$08.00+0 doi:10.1128/MCB.01435-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Wistar Institute, 3601 Spruce Street, Philadelphia, Pennsylvania 19104,1 Department of Medicine, Washington University, St. Louis, Missouri 63110,2 Department of Biological Sciences, Florida Atlantic University, 777 Glades Road, Boca Raton, Florida 334313
Received 9 August 2007/ Returned for modification 24 September 2007/ Accepted 6 March 2008
|
|
|---|
|
|
|---|
The SNAIL protein has emerged as a potent regulator of the processes of embryonic development and tumor progression through the regulation of the epithelial-mesenchymal transition (EMT) (5, 36). In mammalian cells, SNAIL induces EMT at least partially through repression of the E-cadherin gene, thereby altering cell adhesion (6). The SNAIL protein has been found in multiprotein complexes containing histone deacetylases (HDACs), mSIN3A, and LOXL2/3 (39, 40). However, the biological significance of these interactions and how SNAIL mediates functional protein complex assembly at specific promoters in the context of chromatin remain undefined.
We previously identified novel corepressors that directly bind to the SNAG domains of GFI-1 and SNAIL by using yeast two-hybrid assays (3). The AJUBA family of LIM pro teins were identified as prospective candidates which bind to the minimal SNAG domain (3). AJUBA is a multiple LIM domain-containing protein and belongs to the AJUBA/zyxin family of LIM proteins (19). This family includes the AJUBA subfamily AJUBA, LIMD1, and WTIP and the zyxin subfamily zyxin, LPP, and TRIP6. Only the AJUBA subfamily, and not the zyxin subfamily, associated with SNAG domain-containing proteins (31). The AJUBA/zyxin family is characterized by three tandem C-terminal LIM domains and unique N-terminal regions designated the PreLIM regions (19, 26). The AJUBA protein is predominantly cytoplasmic, yet is recruited to E-cadherin-adhesive complexes during epithelium formation and can shuttle between the nucleus and cytoplasm (27). The AJUBA protein may function as a scaffold protein to assemble multiple cytoplasmic protein complexes involved in the processes of cell adhesion, migration, mitosis, and cell differentiation (14, 19, 23). However, its role in the nucleus as a regulator of gene expression is poorly defined.
The in vitro and in vivo studies of the interaction between AJUBA and SNAIL demonstrated that AJUBA functions as a SNAIL corepressor to repress the E-cadherin gene and is recruited to the endogenous E-cadherin promoter in a SNAIL-dependent manner (31). The expression of AJUBA orthologs during the development of Xenopus parallels that of SNAIL, and AJUBA orthologs cooperate with SNAIL and SLUG during the development of the neural crest in Xenopus (31). Since AJUBA itself does not contain an apparent enzymatic activity, we postulated that AJUBA may recruit other effectors to the SNAG domain of SNAIL to modify chromatin structure.
In this study, we purified AJUBA-interacting proteins and we describe the protein arginine methyltransferase 5 (PRMT5) as a candidate in this role. PRMT5 is a type II protein arginine methyltransferase and plays important roles in the regulation of gene transcription (29). Our studies provide strong evidence that PRMT5 is a key component of the SNAIL-silencing complex through binding to AJUBA.
|
|
|---|
The glutathione S-transferase (GST)-AJUBA protein GST-AJUBA (aa 244-350) was generated by PCR amplification of the DNA fragment encoding amino acid residues 244 to 350 of murine AJUBA. The GST-AJUBA mutant (GST-AJUBA LLL-AAA) containing leucine to alanine mutations was generated by using a site-directed mutagenesis kit (Invitrogen). The PCR products were cloned into the BamHI and EcoRI sites of pGEX-4T-1. The truncated Prmt5 plasmids containing PRMT5 (aa 1-170), PRMT5 (aa 169-422), and PRMT5 (aa 421-637) were generated by amplifying the DNA fragment encoding the indicated residues of human PRMT5 and cloning the resulting fragments into the pET-28a vector.
Cell culture, transfections, and luciferase reporter assays. HEK293 cells, U2OS cells, and p19 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 2 mM L-glutamine, and penicillin (50 U/ml)-streptomycin (50 µg/ml) at 37°C under 5% CO2 in a humidified chamber.
For transfection, HEK293 cells were seeded at 5 x 104 cells per well in 24-well plates. The β-galactosidase plasmid (50 ng) and pGL2-E-cad-Luc reporter (200 ng), along with SNAIL- and/or AJUBA-encoding plasmids, were transiently transfected into the cells with Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). Twenty-four hours posttransfection, cells were harvested and lysed. The luciferase and β-galactosidase activities were measured with a luciferase reporter gene assay kit (Promega, Madison, WI) and a β-galactosidase kit (Clontech, Mountain View, CA), respectively. The transfection efficiency among plates was normalized to the β-galactosidase activity level, and all transfections were repeated three times in duplicate.
Affinity purification of a native AJUBA complex and size fractionation. To purify AJUBA-associated proteins, a Flag-tagged, full-length AJUBA cDNA in the pcDNA3.1 vector was stably expressed in HEK293 cells. Single-cell clones were selected with G418 and screened by Western blotting using anti-Flag antibody. A cell clone expressing the Flag-AJUBA protein at a level comparable to that of the endogenous AJUBA was chosen for the purification. A total of 5 x 109 cells were lysed in buffer A containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2.5 mM EDTA, 0.5% NP-40, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), and 0.5 mM dithiothreitol. Cell lysates were precleared with the protein A-agarose beads for 2 h and then incubated with the anti-Flag agarose M2 beads (Sigma, St. Louis, MO) at 0.5 ml of beads per 100 mg of cell lysate for 2 h to overnight with rotation. The M2 beads were washed four times with buffer BC500 containing 20 mM Tris-HCl (pH 7.8), 500 mM KCl, 0.2 mM EDTA, 10% glycerol, 10 mM β-mercaptoethanol, 0.2% NP-40, 0.2 mM PMSF, and 1 µg/ml of aprotinin, leupeptin, and pepstatin. The protein complex was eluted with the Flag peptides (Sigma) at 100 µg/ml in buffer BC100 containing 20 mM Tris-HCl (pH 7.8), 50 mM KCl, 0.2 mM EDTA, 10% glycerol, 10 mM β-mercaptoethanol, 0.2 mM PMSF, and 1 µg/ml of aprotinin, leupeptin, and pepstatin. The eluted proteins were resolved on 4 to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels for Western blotting and silver and colloidal staining analyses. The proteins were excised from the gels and identified by standard mass spectrometry at the Wistar Institute Cancer Center Proteomics Core Facility.
The fractionation of the cell extracts (Superose 6) was carried out according to the manufacturer's instructions and has been described previously (20, 21). Briefly, the column was equilibrated in buffer BC500 prior to the loading of the cell extracts. HEK293 cells were harvested at 48 h posttransfection. Whole-cell extract (1 ml) was prepared in buffer A and was loaded onto the preequilibrated column, which was run at 0.35 ml/min in the cold room and was collected at 0.5 ml per fraction. The protein complex from each fraction was precipitated by using trichloroacetic acid and was resuspended in 100 µl of 0.1 N NaOH solution. To prepare the protein samples for Western blotting, 100 µl of 5x Laemmli buffer was added into each fraction and heated for 5 min, and 50 µl of the protein sample was resolved on a NuPAGE gel (Invitrogen). The proteins were visualized by Western blotting with anti-Myc and anti-Flag monoclonal antibodies.
Coimmunoprecipitation, Western blotting, immunofluorescence, and antibodies. Myc-Ajuba, Flag-Prmt5, and/or Flag-Snail plasmids were transiently transfected into HEK293 cells, and at 24 h posttransfection, the cells were lysed in buffer A. Coimmunoprecipitations were performed with either anti-Myc or anti-Flag antibodies. The Western blotting and immunofluorescence analyses were previously described (24, 46). Mouse monoclonal anti-Myc (Invitrogen) and anti-Flag (Sigma) and rabbit polyclonal anti-SNAIL (Santa Cruz Biotechnology), anti-H4R3 (UPSTATE, Charlottesville, VA), and anti-E-cadherin (Cell Signaling, Danvers, MA) antibodies were purchased. The rabbit polyclonal anti-AJUBA antibody was raised by immunizing rabbits with a bacterially expressed six-His fusion protein of murine AJUBA (amino acids 1 to 216) as the antigen.
siRNA knockdown, methyltransferase inhibitor MTA treatment, and reverse transcriptase PCR. Smart-pool small interfering RNAs (siRNAs) targeting murine Ajuba and Prmt5 (Dharmacon, Lafayette, CO) were transfected into the cells with the Lipofectamine 2000 reagent (Invitrogen). 5'-Deoxy-5'-methyl-thioadenosine (MTA; Sigma) was dissolved in dimethyl sulfoxide. p19 cells were seeded at 1.5 x 105 cells/well in 6-well cell culture plates on day 0. MTA was added into the medium on day 1 at concentrations of 100 µM and 200 µM for 48 h.
Total RNA from p19 cells was isolated with an RNeasy kit (Qiagen, Valencia, CA). The RNA was treated with RQ DNase I to remove any genomic DNA contamination. Two micrograms of the treated total RNA was used for cDNA synthesis in a 20-µl reaction mixture with Superscript II reverse transcriptase (Invitrogen). The primer pairs used for E-cadherin and GAPDH amplification were sense, 5'-GAGAACGGTGGTCAAAGAGC-3', and antisense, 5'-CATCTCCCATGGTGCCACAC-3', and sense, 5'-ACCACAGTCCATGCCATCAC-3', and antisense, 5'-TCCACCCCCTGTTGCTGTA-3', respectively. The PCR amplification was carried out by using Taq DNA polymerase (Promega) at 94°C for 15 s, 60°C for 15 s, and 72°C for 60 s.
ChIP. Chromatin immunoprecipitation (ChIP) experiments were carried out in HEK293 cells stably expressing the Flag-SNAIL cDNA and in p19 cells. HEK293-Flag-SNAIL and HEK293-vector cell lines were established by the transfection of pcDNA3.1 Flag-SNAIL and parental vectors into HEK293 cells and selected with zeocin at 400 ng/ml. The expression of the Flag-SNAIL protein was confirmed by Western blotting. To prepare cells for ChIP, HEK293-Flag-SNAIL and HEK293-vector cells were grown in 150-mm plates to 70 to 90% confluence and fixed by the addition of 574 µl of 37% formaldehyde directly into 20 ml of growth medium to a final concentration of 1% for 20 min in the cell culture incubator. The cross-linking reaction was stopped by the addition of 1.25 ml of 2 M glycine in phosphate-buffered saline buffer at room temperature for 5 min. Cells were harvested, and the ChIP assays were performed according to the protocol supplied with the EZ-CHIP kit (Upstate; catalog no. 17-371). The immunoprecipitated DNAs were amplified with primer set 1: 5'-AATCAGAACCGTGCAGGTCC-3' and 5'-ACAGGTGCTTTGCAGTTCCG-3'. This 250-bp amplicon flanks the three E-boxes located in the proximal promoter region of the E-cadherin gene. Primer set 2, 5'-GGCTCAAGCTATCCTTGCAC-3' and 5'-GTGCAGTGGCTCATGTCTGT-3', was used to amplify a 197-bp fragment carried by exon 16 of the E-cadherin gene. The PCR fragments were cloned, and their identities were confirmed by DNA sequencing. For quantitation, the PCR products were resolved on 2% agarose gels and visualized with ethidium bromide.
p19-siAjuba and p19-siLuc (small interfering luciferase) cells were established as previously described (31). Retroviral vectors containing short hairpin RNAs targeting murine Ajuba (GGAGAGCCGTCACTCGTAC) and the luciferase gene were introduced into p19 cells and selected with puromycin. The resulting pooled p19-siAjuba and p19-siLuc cells were verified by Western blotting and were used for ChIP assays. The ChIP assays were performed essentially as described above for HEK293 cells. The primer sets used to amplify the murine E-cadherin promoter were set 1 forward, 5'-AGACAGGGGTGGAGGAAGTT-3', and reverse, 5'-GGGCAGGAGTCTAGCAGAAG-3', and set 2 forward, 5'-AGGTATCTTGGTGTGGGTGCAACT-3', and reverse, 5'-ACGCCAAGAAACTTAAGTGGTGCC-3'. The resulting DNA samples were analyzed with real-time PCR as described previously (32).
|
|
|---|
![]() View larger version (33K): [in a new window] |
FIG. 1. Affinity purification of AJUBA-interacting proteins. (A) Diagram showing the architectures of the SNAIL and AJUBA proteins. The shaded bar in the PreLIM region contains a potential nuclear box motif. (B) AJUBA can augment SNAIL-mediated repression of the promoter-luciferase reporter activities of E-cadherin in HEK293 cells. Error bars show standard deviations. RLU, relative light units; +, present; –, absent. (C) Colloidal staining shows the potential AJUBA-interacting proteins purified from HEK293 cells. The asterisk shows vimentin. The prestained molecular mass marker (Benchmarker; Invitrogen) migrates 15 to 20 kDa faster than the predicted molecular size. Molecular sizes are shown on the left. IP, immunoprecipitation.
|
![]() View larger version (34K): [in a new window] |
FIG. 2. PRMT5 is a novel AJUBA-interacting protein. (A) The exogenously expressed PRMT5 and AJUBA proteins interact in HEK293 cells. Molecular sizes are shown on the left. The asterisk shows nonspecific bands. (B) The endogenous AJUBA and PRMT5 proteins interact in p19 cells. Immunoprecipitation was performed with anti-AJUBA polyclonal antibody, and preimmune rabbit immunoglobulin G was used as control. The immunoprecipitated proteins were resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, and Western blotting was performed with monoclonal anti-PRMT5 antibody. +, present; –, absent; , anti; IP, immunoprecipitation; Wb, Western blot; PI, preimmune serum.
|
![]() View larger version (41K): [in a new window] |
FIG. 3. A single domain in the PreLIM region is essential for PRMT5 binding. (A) Diagram showing the progressive deletions of AJUBA. (B) The PreLIM region of AJUBA binds to PRMT5. Molecular sizes are shown on the left. The asterisk shows nonspecific bands. (C) The region between amino acid residues 279 and 312 of AJUBA binds to PRMT5. Plasmids were transfected into HEK293 cells. Immunoprecipitations (IP) were carried out with anti-Myc antibody, and Western blotting (Wb) was performed with anti-Flag antibody. +, present; –, absent; , anti.
|
![]() View larger version (46K): [in a new window] |
FIG. 4. Multiple domains in PRMT5 interact with AJUBA. (A) Diagram showing the full-length PRMT5, its truncations, and the GST-AJUBA constructs. +, positive. (B) Full-length PRMT5 binds WT GST-AJUBA, but not the mutant. Molecular sizes are shown on the left. +, present. (C) All three PRMT5 truncations can bind the WT GST-AJUBA. Bacterially expressed and purified GST-AJUBA (aa 244-350) and its mutant with mutations of leucines to alanines were incubated with in vitro-translated PRMT5 proteins. Molecular sizes are shown on the left. +, present.
|
![]() View larger version (28K): [in a new window] |
FIG. 5. PRMT5 is translocated into the nucleus through interaction with AJUBA and SNAIL. (A) Subcellular localization of AJUBA and PRMT5 in U2OS cells. The plasmids encoding Myc-AJUBA and Flag-PRMT5 were transiently transfected into U2OS cells, and immunofluorescent images were taken with confocal microscopy. AJUBA is predominately cytoplasmic when expressed alone, and PRMT5 is cytoplasmic with a distribution pattern similar to that of AJUBA (top panel). The coexpression of AJUBA and PRMT5 is shown in the bottom panel. (B) Individual expression of PRMT5, SNAIL, RFP-AJUBA, and RFP in U2OS cells. When expressed alone, the SNAIL protein is localized in the nucleus, while the RFP-AJUBA and PRMT5 proteins are in the cytoplasm; RFP alone is found in both cytoplasm and nucleus. (C) The coexpression of RFP and SNAIL does not affect their localization. (D) The coexpression of AJUBA and SNAIL affects both of their localizations: the SNAIL protein is retained in the cytoplasm, and concomitantly, a significant amount of the AJUBA protein is localized in the nucleus. (E) The coexpression of PRMT5, RFP, and SNAIL reveals no apparent effect on either localization. (F) The coexpression of RFP-AJUBA, SNAIL, and PRMT5 results in a significant amount of the PRMT5 protein being relocated to the nucleus and colocalized with nuclear SNAIL and AJUBA.
|
![]() View larger version (29K): [in a new window] |
FIG. 6. The AJUBA protein can simultaneously immunoprecipitate SNAIL and PRMT5. (A) Coimmunoprecipitation of the SNAIL, AJUBA, and PRMT5 proteins. The plasmids encoding Myc-AJUBA, Flag-SNAIL, and Flag-PRMT5 were transiently transfected into HEK293 cells, and immunoprecipitation (IP) was done with anti-Myc antibody and Western blotting (Wb) with anti-Flag antibody. The asterisk shows nonspecific bands. +, present; –, absent; , anti. (B) Western blots show the eluted SNAIL, AJUBA, and PRMT5 proteins from the Superose 6 sizing column. Whole-cell extract (8 mg) was prepared from HEK293 cells transiently expressing Myc-AJUBA, Flag-SNAIL, and Flag-PRMT5 and was loaded onto a Superose 6 gel filtration column. Molecular sizes are shown on the left. MM, molecular mass.
|
![]() View larger version (37K): [in a new window] |
FIG. 7. SNAIL, AJUBA, and PRMT5 are associated with the E-cadherin gene at the proximal promoter. (A) Western blot analysis of the expression of the Flag-SNAIL, AJUBA, PRMT5, and E-cadherin proteins in HEK293 cells indicates that the E-cadherin gene is downregulated by the overexpression of Flag-SNAIL. (B) Diagram illustrating the human E-cadherin promoter and the PCR primers used for ChIP. A, B, and C in the boxes indicate the three SNAIL-binding sites in the promoter. (C) PCR analysis of the immunoprecipitated DNA fragments. Molecular sizes are shown on the right. PI, preimmune serum. Numbers above the input lanes indicate dilutions of the input DNAs in water (1, no dilution). (D) Analysis of the ChIP assay results using real-time PCR in p19-siAjuba and p19-siLuc cells, and diagram illustrating the murine E-cadherin promoter and the PCR primers used for ChIP. E in the box in the diagram indicates the SNAIL binding site. Error bars show standard deviations. IgG, immunoglobulin G; , anti.
|
Modulation of AJUBA and PRMT5 in p19 cells results in upregulation of E-cadherin expression. Since the nucleus-localized SNAIL-AJUBA-PRMT5 complex can be found at the E-cadherin promoter, we sought to determine whether this well-established SNAIL target gene was targeted by this ternary complex. It has been previously found that the induction of SNAIL protein in p19 cells repressed E-cadherin gene expression, while the depletion of SNAIL protein resulted in the upregulation of the SNAIL target genes (10, 35). To test the roles of AJUBA and PRMT5 in the regulation of the expression of endogenous E-cadherin, an siRNA targeting murine Ajuba was transfected into the p19 cells. The level of the AJUBA protein was significantly decreased by the siRNA (Fig. 8A). Moreover, the expression of E-cadherin at both the mRNA and protein levels was significantly increased (Fig. 8A and B). These results suggest that AJUBA is involved in the repression of E-cadherin gene expression.
![]() View larger version (39K): [in a new window] |
FIG. 8. Modulation of AJUBA and PRMT5 in p19 cells results in upregulation of E-cadherin expression. (A) Western blotting results show that siRNA targeting AJUBA can stimulate E-cadherin gene expression in p19 cells. Molecular sizes are shown on the left. The asterisk shows nonspecific bands. (B) Reverse transcriptase PCR (RT-PCR) analysis of the E-cadherin mRNA level in siAjuba p19 cells. Molecular sizes are shown on the left. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (C and D) The methyltransferase inhibitor MTA stimulates E-cadherin expression in p19 cells (C), and similarly, siRNA knockdown of PRMT5 in p19 cells results in the upregulation of E-cadherin gene expression (D), shown by the results of Western blotting.
|
|
|
|---|
The PRMT5 protein is a member of the type II protein arginine methyltransferases and can methylate transcription factors and histones on specific arginine residues to regulate gene expression (2, 13, 37, 38). For example, PRMT5 was found to interact with BRG1 and BRM, components of the human SWI/SNF chromatin-remodeling complex, to methylate histones H2A and H4 on arginine 3 and H3 on arginine 8. These activities of PRMT5 result in the repression of genes, such as ST7 and NM23, and the promotion of a tumorigenic state in NIH 3T3 cells (37, 38). PRMT5 can interact with Blimp1, a zinc finger transcriptional repressor, and suppresses the expression of Dhx38 by the methylation of histones H2A and H4 on arginine 3 (2). The PRMT5 protein has also been found to be part of the E2F complex in the cyclin E1 promoter, correlating with the repression of the transcription of the cyclin E1 gene (13).
The evidence described above suggests that PRMT5 is involved in the transcriptional repression. Paradoxically, the majority of the PRMT5 protein at steady state is found in the cytoplasm. How PRMT5 is translocated, retained, and targeted to specific genes in the nucleus is not clear. We demonstrate that PRMT5 can be translocated into the nucleus via the formation of a complex with AJUBA and SNAIL and that SNAIL may function as a nuclear anchor to target PRMT5 to its target genes.
The MEP50 protein is also found in the AJUBA-PRMT5 complex. The MEP50 protein contains WD motifs and is constitutively associated with the PRMT5 protein (17, 18). Several WD motif-containing proteins were recently shown to be essential for global histone methylation and the regulation of gene transcription (47). The MEP50 protein was shown to direct PRMT5 to specific histones and is indispensable for PRMT5-dependent histone modification (18). Further work will be necessary to establish the role of MEP50 in SNAIL-mediated gene repression and PRMT5 function.
The SNAIL family of proteins play key roles in the regulation of EMT events during development and metastasis and also serve as early markers for the malignant phenotype and prognosis (4, 5, 7, 11, 30, 34). Recently, Snail was shown to be spontaneously upregulated during the process of tumor recurrence in mice, and high levels of Snail expression strongly predict decreased relapse-free survival in women with breast cancer (34). These observations strongly imply a critical role of Snail in the process of breast cancer recurrence. Therefore, the identification of proteins involved in SNAIL-dependent repression will not only shed new light for understanding the mechanisms of SNAIL in EMT and tumor recurrence but also provide new targets for potential drug development and diagnostics.
Previous studies have demonstrated the association of SNAIL with potential coregulators through its SNAG domain. These include HDAC1, HDAC2, and the corepressor mSIN3A (39). HDACs are commonly found in large protein complexes in vivo both in the cytoplasm and in the nucleus and may direct the regulation of gene expression, the cell cycle, differentiation, and DNA repair. HDAC1 and HDAC2 have been shown to associate with SMRT, the CoREST complex, mSIN3, N-CoR, and Mi-2/NuRD and play essential roles in gene silencing (12, 41). However, how SNAIL mediates the complex assembly remains elusive. Here, we showed that AJUBA recruits PRMT5 via its PreLIM region to the SNAG domain of SNAIL (Fig. 9). Since both HDAC1 and HDAC2 and AJUBA-PRMT5 interact with the SNAG domain of SNAIL, it will be interesting to examine the complementary roles of these enzymes in SNAIL-mediated repression.
![]() View larger version (18K): [in a new window] |
FIG. 9. Model for the roles of AJUBA and PRMT5 in SNAIL-mediated gene repression. Small circles, methyl groups; hatched oblongs, nucleosomes; wiggly lines, histone tails.
|
F.J.R. is supported, in part, by NIH grants (CA095561 and CA092088) and grant DAMD17-02-1-0631 from the Pardee foundation, by the Emerald foundation, and by the Samuel Waxman Cancer Research Foundation. Z.H. is supported by an NIH training grant (T32, CA09171-31A1). G.D.L. is supported by NIH grants (CA75315 and CA106496) and the Washington University/Pfizer Biomedical Research Program. E.M.L. is an HHMI predoctoral fellow. We acknowledge the National Cancer Institute-supported Wistar Institute Cancer Center shared facilities for genomics, protein expression, proteomics, and hybridoma and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health. K.A. is supported by NIH grant KO1-CA095620.
Published ahead of print on 17 March 2008. ![]()
|
|
|---|
B activation by affecting the assembly and activity of the protein kinase C
/p62/TRAF6 signaling complex. Mol. Cell. Biol. 25:4010-4022.
. Mol. Cell. Biol. 25:3956-3966.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»